UDC 547.793

O-ALKILIROVANIE 4-GIDROKSIBENZOLSUL'FONAMIDA N-ZAMESHCHENNYMI 2-HLORACETAMIDAMI I 5 (HLORMETIL)-3-ARIL-1,2,4-OKSADIAZOLAMI O-alkilirovanie 4-gidroksibenzolsul'fonamida N-zameshchennymi 2-hloracetamidami i 5 (hlormetil)-3-aril-1,2,4-oksadiazolami

Published in From Chemistry Towards Technology Step-By-Step · Volume 5, Issue 4 · Pages 8–15 · Rubric: Scientific articles
DOI: https://doi.org/10.52957/2782-1900-2024-5-4-8-15
Received: 01.11.2024 Accepted: 19.11.2024 Published: 23.12.2024
Razrabotan sposob sinteza novyh predstaviteley klassa pervichnyh benzolsul'fonamidov, perspektivnyh agentov dlya lecheniya otkrytougol'noy glaukomy i neyrodegenerativnyh zabolevaniy. Byla razrabotana metodika O-alkilirovaniya 4 gidroksibenzolsul'fonamida alkiliruyuschimi agentami razlichnoy prirody, obespechivayuschaya myagkie usloviya i selektivnost' processa. Pokazana neobhodimost' aktivacii N-zameschennyh 2-hloracetamidov i 5-(hlormetil)-3-aril-1,2,4-oksadiazolov kataliticheskoy dobavkoy yodida kaliya v reakciyah O-alkilirovaniya fenolov. Primenimost' razrabotannoy metodiki prodemonstrirovana na 12 primerah sinteza O alkilproizvodnyh 4-gidroksibenzolsul'fonamida, poluchennyh s vyhodami ot 28 do 86%. Chistota i stroenie novyh soedineniy dokazany sovokupnost'yu metodov YaMR 1N, 13S i elementnogo analiza.
sul'fanilamid, oksadiazol, O-alkilirovanie, karboangidraza, monoaminooksidaza
Funding
Stat'ya podgotovlena v ramkah gosudarstvennogo zadaniya Yaroslavskogo gosudarstvennogo pedagogicheskogo universiteta im. K. D. Ushinskogo na 2024 god ot Minprosvescheniya RF po teme «Razrabotka novogo lekarstvennogo sredstva dlya lecheniya neyrodegenerativnyh zabolevaniy na osnove ingibitora monoaminoksidazy» (nomer reestrovoy zapisi 720000F.99.1.BN62AA12000)
Text References
Text (PDF)
Read Download

1. Kricman V.A., Stanco V. V. Lekarstvennye veschestva. Enciklopedicheskiy slovar' yunogo himika. 2-e izd. 1990. S. 134—136.

2. Sarnpitak P., Mujumdar P., Morisseau C., Hwang S.H., Hammock B., Iurchenko V., Krasavin M. Potent, orally available, selective COX-2 inhibitors based on 2-imidazoline core // Eur. J. Med. Chem. 2014. 84. pp. 160 172. DOI:https://doi.org/10.1016/j.ejmech.2014.07.023.

3. Verweij J., Sleijfer S. Pazopanib, a new therapy for metastatic soft tissue sarcoma // Expert Opin Pharmacother. 2013, 14(7), 929–935. DOI:https://doi.org/10.1517/14656566.2013.780030.

4. Mboge M. Y., Combs J., Singh S., Andring J., Wolff A., Tu C., Frost S. C. Inhibition of Carbonic Anhydrase Using SLC-149: Support for a Noncatalytic Function of CAIX in Breast Cancer // J Med Chem. 2021. 64(3). 1713–1724. DOI:https://doi.org/10.1021/acs.jmedchem.0c02077.

5. Kalinin S, Malkova A, Sharonova T, Sharoyko V, Bunev A, Supuran CT, Krasavin M. Carbonic Anhydrase IX Inhibitors as Candidates for Combination Therapy of Solid Tumors // Int J Mol Sci. 2021. 22(24):13405. DOI:https://doi.org/10.3390/ijms222413405.

6. Khokhlov A. L., Shetnev A. A., Korsakov M. K., Fedorov V. N., Tyushina A. N., Volkhin N. N., Vdovichenko V. P. Pharmacological Properties of Sulfonamide Derivatives, New Inhibitors of Carbonic Anhydrase // Bull Exp Biol Med. 2023. 175(2). 205-209.

7. Gasilina O. A., Romanycheva A. A., Shetnev A. A., Korsakov M. K. Synthesis, Antibacterial, and Antimonooxidase Activity of 4-(2-Methyl-1, 3-oxazol-5-yl) benzenesulfonamide // Rus. J. Gen Chem. 2023. 93(11). 2749-2755.

8. Krasavin M., Shetnev A., Baykov S., Kalinin S., Nocentini A., Sharoyko V., Supuran C. T. Pyridazinone substituted benzenesulfonamides display potent inhibition of membrane-bound human carbonic anhydrase IX and promising antiproliferative activity against cancer cell lines // Eur. J. Med Chem. 2019. 168. 301-314.

9. Shetnev A., Shlenev R., Efimova J., Ivanovskii S., Tarasov A., Petzer A., Petzer, J. P. 1, 3, 4-Oxadiazol-2-ylbenzenesulfonamides as privileged structures for the inhibition of monoamine oxidase B // Bioorg Med Chem Lett. 2019. 29(21). 126677.

10. Bao, X., Song, D., Qiao, X., Zhao, X., & Chen, G. The Development of an Effective Synthetic Route of Belinostat // Org Process Res Dev. 2016. 20(8). 1482-1488. DOI:https://doi.org/10.1021/acs.oprd.6b00170.

11. Patent SShA 10064869 MTH1 inhibitors for treatment of inflammatory and autoimmune conditions / Scobie M., Wallner O., Koolmeister T., Vallin K.S.A., Henriksson C.M., Homan E., Helleday T., Jacques S., Desroses M., Jacques-Cordonnier M.-C. Opubl. 2018.

12. Dyadyuchenko L. V., Dmitrieva I. G., Nazarenko D. Yu., Strelkov V. D. Sintez nekotoryh zameschennyh piridin-sul'fohloridov, sul'fokislot i sul'fonilamidov // Himiya geterociklicheskih soedineniy. 2014. № 9. S. 1366-1377.

13. Flipo M., Willand N., Lecat-Guillet N., Hounsou C., Desroses M., Leroux F., Déprez B. Discovery of Novel N-Phenylphenoxyacetamide Derivatives as EthR Inhibitors and Ethionamide Boosters by Combining High Throughput Screening and Synthesis // J.Med. Chem. 2012. 55(14). 6391–6402. DOIhttps://doi.org/10.1021/jm300377g.

14. Baughman T. W., Sworen J. C., Wagener K. B. The facile preparation of alkenyl metathesis synthons // Tetrahedron. 2004. 60. 10943-10948.

15. Kulikova E. A., Basanova E. I., Perevalov V. P., Nikitina P. A. Alkilirovanie 1-gidroksiimidazolov // Uspehi v himii i himicheskoy tehnologii. XXXVI. 2022. № 8. S. 97-99.

16. Poplavskaya I.A., Kurmangalieva R.G. Himiya amidoksimov. Alma-Ata: Nauka. 1988. 144 s.

17. Dürüst Y., Karakus H., Kaiser M., Tasdemir D. Synthesis and antiprotozoal activity of novel dihydropyrrolo[3,4-d][1,2,3]triazoles // Eur. J. Med. Chem. 2012. V. 48. R. 296-304. DOI:https://doi.org/10.1016/j.ejmech.2011.12.028.